Regatta Capital Group LLC Acquires 174 Shares of Cencora, Inc. (NYSE:COR)

Regatta Capital Group LLC raised its stake in Cencora, Inc. (NYSE:COR) by 2.0% during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission. The fund owned 8,750 shares of the company’s stock after buying an additional 174 shares during the period. Regatta Capital Group LLC’s holdings in Cencora were worth $1,966,000 as of its most recent SEC filing.

A number of other institutional investors and hedge funds have also added to or reduced their stakes in COR. Public Sector Pension Investment Board boosted its position in shares of Cencora by 39.4% during the 2nd quarter. Public Sector Pension Investment Board now owns 4,508 shares of the company’s stock valued at $1,016,000 after purchasing an additional 1,274 shares in the last quarter. Evergreen Capital Management LLC grew its position in shares of Cencora by 4.7% during the 2nd quarter. Evergreen Capital Management LLC now owns 1,147 shares of the company’s stock worth $258,000 after buying an additional 52 shares during the period. Marshall Wace LLP bought a new stake in shares of Cencora in the 2nd quarter valued at $1,539,000. MBB Public Markets I LLC lifted its position in shares of Cencora by 920.0% during the 2nd quarter. MBB Public Markets I LLC now owns 12,648 shares of the company’s stock valued at $2,850,000 after acquiring an additional 11,408 shares during the period. Finally, The Manufacturers Life Insurance Company boosted its stake in Cencora by 4.0% during the second quarter. The Manufacturers Life Insurance Company now owns 489,238 shares of the company’s stock worth $110,225,000 after acquiring an additional 18,935 shares in the last quarter. Institutional investors and hedge funds own 97.52% of the company’s stock.

Insider Activity

In other Cencora news, EVP Silvana Battaglia sold 1,678 shares of the business’s stock in a transaction dated Friday, December 20th. The shares were sold at an average price of $228.72, for a total value of $383,792.16. Following the transaction, the executive vice president now directly owns 20,329 shares in the company, valued at $4,649,648.88. The trade was a 7.62 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Also, Chairman Steven H. Collis sold 50,000 shares of Cencora stock in a transaction that occurred on Monday, November 25th. The stock was sold at an average price of $243.97, for a total transaction of $12,198,500.00. Following the completion of the sale, the chairman now directly owns 326,557 shares in the company, valued at $79,670,111.29. This trade represents a 13.28 % decrease in their position. The disclosure for this sale can be found here. Insiders sold a total of 73,187 shares of company stock valued at $17,790,912 over the last three months. Corporate insiders own 15.80% of the company’s stock.

Analyst Ratings Changes

COR has been the subject of several research analyst reports. Evercore ISI lifted their price target on shares of Cencora from $250.00 to $285.00 and gave the company an “outperform” rating in a research note on Thursday, November 7th. Mizuho began coverage on Cencora in a research note on Wednesday, December 4th. They set an “outperform” rating and a $280.00 price target on the stock. Barclays raised their price objective on Cencora from $263.00 to $290.00 and gave the company an “overweight” rating in a research note on Thursday, November 7th. Robert W. Baird increased their target price on Cencora from $287.00 to $292.00 and gave the stock an “outperform” rating in a report on Thursday, November 7th. Finally, UBS Group boosted their price target on shares of Cencora from $275.00 to $285.00 and gave the company a “buy” rating in a research note on Thursday, November 7th. Two equities research analysts have rated the stock with a hold rating and ten have issued a buy rating to the company. According to data from MarketBeat, the stock currently has an average rating of “Moderate Buy” and an average price target of $277.00.

Cencora Stock Up 0.2 %

COR opened at $248.45 on Friday. Cencora, Inc. has a fifty-two week low of $214.77 and a fifty-two week high of $253.27. The company has a debt-to-equity ratio of 4.84, a current ratio of 0.88 and a quick ratio of 0.53. The company’s 50-day moving average is $237.51 and its 200 day moving average is $234.75. The firm has a market capitalization of $48.02 billion, a P/E ratio of 33.08, a PEG ratio of 1.54 and a beta of 0.49.

Cencora Increases Dividend

The firm also recently announced a quarterly dividend, which was paid on Friday, November 29th. Stockholders of record on Friday, November 15th were paid a $0.55 dividend. This represents a $2.20 dividend on an annualized basis and a dividend yield of 0.89%. The ex-dividend date was Friday, November 15th. This is an increase from Cencora’s previous quarterly dividend of $0.51. Cencora’s payout ratio is presently 29.29%.

Cencora Company Profile

Cencora, Inc sources and distributes pharmaceutical products. The company's U.S. Healthcare Solutions segment distributes pharmaceuticals, over-the-counter healthcare products, home healthcare supplies and equipment, and related services to acute care hospitals and health systems, independent and chain retail pharmacies, mail order pharmacies, medical clinics, long-term care and alternate site pharmacies, and other customers; provides pharmacy management, staffing, and other consulting services; supply management software to retail and institutional healthcare providers; packaging solutions to various institutional and retail healthcare providers; clinical trial support, product post-approval, and commercialization support services; data analytics, outcomes research, and additional services for biotechnology and pharmaceutical manufacturers; pharmaceuticals, vaccines, parasiticides, diagnostics, micro feed ingredients, and other products to the companion animal and production animal markets; and sales force services to manufacturers.